STOCK TITAN

MariMed Announces Fourth Quarter and Full Year 2024 Earnings Date

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

MariMed Inc. (CSE: MRMD, OTCQX: MRMD), a multi-state cannabis operator, has scheduled its fourth quarter and full year 2024 earnings release for March 5, 2025, after market close. The company will host a conference call to discuss the financial results on March 6, 2024, at 8:00 a.m. EST. A webcast will be available through MariMed's Investor Relations website, with a playback option provided afterward.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

-0.38%
1 alert
-0.38% News Effect

On the day this news was published, MRMD declined 0.38%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

NORWOOD, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, announced today it will report fourth quarter and full year 2024 financial results on March 5, 2025 after the markets close. Management will host a conference call on March 6, 2024, at 8:00 a.m. EST to discuss financial results.

A webcast will be available and can be accessed via MariMed’s Investor Relations website at MariMed Q424 Earnings Webcast. A playback of the call will also be made available on MariMed’s Investor Relations website.

About MariMed
MariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby’s Baked™, Vibations™, InHouse™, and Nature’s Heritage™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit www.marimedinc.com.

Company Contact:
Howard Schacter
Chief Communications Officer
Email: ir@marimedinc.com
Phone: (781) 277-0007


FAQ

When will MariMed (MRMD) release its Q4 2024 earnings?

MariMed will release its Q4 and full year 2024 earnings on March 5, 2025, after market close.

What time is MariMed's (MRMD) Q4 2024 earnings call?

MariMed's Q4 2024 earnings conference call is scheduled for March 6, 2024, at 8:00 a.m. EST.

How can investors access MariMed's (MRMD) Q4 2024 earnings call?

Investors can access the earnings call through a webcast available on MariMed's Investor Relations website.

Will there be a replay available for MariMed's (MRMD) Q4 2024 earnings call?

Yes, a playback of the earnings call will be made available on MariMed's Investor Relations website.
Marimed

OTC:MRMD

MRMD Rankings

MRMD Latest News

MRMD Latest SEC Filings

MRMD Stock Data

56.49M
280.32M
14.7%
0.24%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Norwood